Concord Asset Management (Virginia)’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-21,483
Closed -$2.14M 137
2024
Q4
$2.14M Sell
21,483
-23,232
-52% -$2.4M 0.47% 56
2024
Q3
$5.08M Buy
44,715
+12,075
+37% +$1.43M 1.15% 24
2024
Q2
$4.04M Buy
32,640
+3,492
+12% +$450K 1% 27
2024
Q1
$3.85M Buy
29,148
+2,489
+9% +$307K 1.01% 27
2023
Q4
$2.91M Buy
26,659
+7,892
+42% +$819K 0.85% 28
2023
Q3
$1.93M Buy
18,767
+6,137
+49% +$661K 0.65% 30
2023
Q2
$1.46M Buy
12,630
+2,848
+29% +$323K 0.51% 33
2023
Q1
$1.04M Buy
+9,782
New +$1.06M 0.43% 35

Other funds holding MRK

Concord Asset Management (Virginia)'s MRK Position: Q1 2025 in Review

Concord Asset Management (Virginia) sold out of Merck (MRK) in Q1 2025, closing a stake of 21,483 shares — an estimated $2.14M sold.

Concord Asset Management (Virginia) first reported a position in MRK in Q1 2023 and held it in 8 quarters. The position peaked at $5.08M in Q3 2024. 3,447 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • Concord Asset Management (Virginia) reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • Concord Asset Management (Virginia) sold 21,483 Merck shares in Q1 2025, an estimated $2.14M.
  • Concord Asset Management (Virginia) first reported a position in Merck in Q1 2023 and held it in 8 quarters.
  • Concord Asset Management (Virginia)'s Merck position peaked at $5.08M in Q3 2024.
  • 3,447 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Concord Asset Management (Virginia)'s 13F filing for Q1 2025, filed 2 May 2025.